Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 40 papers were listed this time. Here's a handful in our areas of research interest:
Tunis SL. Cost Effectiveness of Self-Monitoring of Blood Glucose (SMBG) for Patients with Type 2 Diabetes and Not on Insulin: Impact of Modelling Assumptions on Recent Canadian Findings. Appl Health Econ Health Policy. 2011 Nov 1;9(6):351-65. PubMed PMID: 21892840.
Scotland G, Waugh N, Royle P, et al. Denosumab for the prevention of osteoporotic fractures in post-menopausal women: a NICE single technology appraisal. Pharmacoeconomics. 2011 Nov 1;29(11):951-61. PubMed PMID: 21854080.
Price D, Gray A, Gale R, et al. Cost-utility analysis of indacaterol in Germany: a once-daily maintenance bronchodilator for patients with COPD. Respir Med. 2011 Nov;105(11):1635-47. Epub 2011 Jul 20. PubMed PMID: 21764277.
Campbell HE, Epstein D, Bloomfield D, et al. The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses. Eur J Cancer. 2011 Nov;47(17):2517-30. Epub 2011 Jul 7. PubMed PMID: 21741831.